Migraine Headache Newswire

Migraine Headache Newswire

Comprehensive Real-Time News Feed for Migraine Headache.

Results 1 - 20 of 307 in Migraine Headache

  1. Opioids Overused in Migraine Treatment, Regardless of RaceRead the original story

    1 hr ago | Health News Digest

    An investigation into racial disparities in migraine treatment came up empty, but instead it found a different concern that reaches across populations. African-Americans are more likely to experience debilitating migraine headaches than whites, but a new study probing the issue found no evidence of racial disparities in treatment practices.

    Comment?

  2. Opioids overused in migraine treatment, regardless of race, study findsRead the original story w/Photo

    5 hrs ago | PhysOrg Weblog

    African-Americans are more likely to experience debilitating migraine headaches than whites, but a new study probing the issue found no evidence of racial disparities in treatment practices. Credit: University of Michigan African-Americans are more likely to experience debilitating migraine headaches than whites, but a new study probing the issue found no evidence of racial disparities in treatment practices.

    Comment?

  3. Kidney donor, recipient have special connectionRead the original story w/Photo

    19 hrs ago | Courier-Tribune

    Natalie Caviness, who will celebrate her 26th birthday Saturday, did not realize that there would be extra perks from dating her boyfriend, Shane Morgan. Caviness, who received a donor kidney from Morgan's father, Steve, on Tuesday, and according to family and friends is doing very well after surgery, had been diagnosed with a rare kidney disease She was immediately told by doctors that she needed a kidney transplant and Steve Morgan stepped in and volunteered to donate one of his.

    Comment?

  4. CRAWFORD | Kyle Kuric and Joey Cecil: Brain tumor stories, and a meeting of the mindsRead the original story w/Photo

    Friday Aug 11 | WDRB-TV Louisville

    Joey Cecil, who underwent brain surgery in April to remove a fast-growing malignant tumor, attempts a shot in a game of H-O-R-S-E against Kyle Kuric, who survived his own brain tumor scare. Joey Cecil attempts a shot off the steps in a game of H-O-R-S-E against Kyle Kuric Friday.

    Comment?

  5. Holly Lasnetski v. Secretary of Health and Human ServicesRead the original story w/Photo

    Tuesday Aug 1 | FindLaw

    Before LOURIE, REYNA, and HUGHES, Circuit Judges.RANDALL GORDON KNUTSON, Knutson Casey Law Firm, Mankato, MN, for petitioner-appellant. DEBRA ANN FILTEAU BEGLEY, Vaccine/Torts Branch, Civil Division, United States Department of Justice, Washington, DC, for respondent-appellee.

    Comment?

  6. Jim Cramer Says Allergan Shares Are 'Just Too Cheap'Read the original story w/Photo

    Friday Aug 11 | TheStreet.com

    Allergan is such a good pharmaceutical play that Jim Cramer, who already owns the name in his charitable trust, plans to buy even shares more if the stock pulls back from here. "Here's a company with a 9% increase in revenues that sells more cheaply than all of the other major pharmas.

    Comment?

  7. HeadAid Products Soon to be Available on Go4ItNutrition.comRead the original story

    Friday Aug 11 | PRWeb

    HeadAid, a supplement known for its ability to provide natural and effective relief from severe headaches, migraines and nausea, is growing in popularity, as evidenced by its availability through Go4ItNutrition. HeadAid, a supplement known for its ability to provide natural and effective relief from severe headaches, migraines and nausea, is growing in popularity, as evidenced by its availability through Go4ItNutrition.

    Comment?

  8. Neuro clinic shuts doors after 40+ years, leaving hundreds stunnedRead the original story w/Photo

    Wednesday Aug 9 | KSL-TV

    Western Neurological Associates, 3900 S 1151 East, is locked, the phones are disconnected, the power is off and there's a sign on the door that reads the business closed due to "unfortunate circumstances." Hundreds of patients with neurological conditions like seizures, migraines and dementia found out this week that their neurological clinic suddenly shut its doors after more than 40 years in business.

    Comment?

  9. Myths and misconceptionsRead the original story w/Photo

    Tuesday Aug 8 | Canadian HR Reporter

    Canadian Occupational Safety magazine brings you daily news, advice and information from across the country and around the world. Check in daily to find out what's new in OHS news.

    Comment?

  10. Everyday Cheapskate: The wonders of Epsom saltRead the original story w/Photo

    Tuesday Aug 8 | Red Bluff Daily News

    I can recall vividly - and count on one hand - the migraine headaches I've had in my life, all of which were before age 10. Once I turned double digits, I outgrew them ... until a couple of months ago. With no warning at all, there I was back to my 8-year-old self, flat on my back with a raging migraine.

    Comment?

  11. Theater Review: "Moscow Moscow Moscow Moscow Moscow Moscow" @ Williamstown [Berkshire on Stage]Read the original story w/Photo

    Thursday Aug 3 | Nippertown!

    Anton Chekhov's The Three Sisters is recognized as one of the modern theater's greatest plays. First produced in 1901, this story of loneliness, disillusionment and its challenging roles continue to attract actors and directors all through the western world.

    Comment?

  12. Electroceuticals/Bioelectric Medicine Market worth 25.20 Billion USD by 2021Read the original story

    Thursday Aug 3 | Emailwire.com

    A number of factors such as rising geriatric population, regulatory approval for new and advanced electroceuticals, growing investments and funds for the development of novel therapies and electroceuticals, rising prevalence of neurological disorders, and growing prevalence of hearing loss are expected to drive the growth of the electroceuticals/bioelectric medicine market during the forecast period. In this report, the global electroceuticals/bioelectric medicine market is segmented on the basis of product, type of device, application, end user, and region.

    Comment?

  13. Davis' career was short but Hall-of-Fame sweetRead the original story w/Photo

    Wednesday Aug 2 | Denton Record-Chronicle

    In between the magnificence and the migraines, Terrell Davis' NFL voyage was bookended by two bone-crushing hits that came to define a career remembered as much for its brevity as its brilliance. Davis was just another lost-in-the-shuffle rookie in 1995 filled with doubts when the Denver Broncos traveled to Tokyo for an exhibition game against the San Francisco 49ers.

    Comment?

  14. Davis' NFL career was short, but oh so sweetRead the original story w/Photo

    Wednesday Aug 2 | Santa Fe New Mexican

    Broncos running back Terrell Davis holds the Lombardi trophy after Denver beat the Packers 31-24 in Super Bowl XXXII on Jan. 25, 1998, in San Diego. Davis will be inducted into the Pro Football Hall of Fame on Saturday.

    Comment?

  15. HOF Series: Davis' NFL career was short but oh so sweetRead the original story w/Photo

    Wednesday Aug 2 | The Galveston County Daily News

    In between the magnificence and the migraines, Terrell Davis' NFL voyage was bookended by two bone-crushing hits that came to define a career remembered as much for its brevity as its brilliance. Davis was just another lost-in-the-shuffle rookie back in 1995 filled with doubts when the Denver Broncos traveled to Tokyo for an exhibition game against the San Francisco 49ers.

    Comment?

  16. Woman's Vision Restored Following ChiropracticRead the original story w/Photo

    Tuesday Aug 1 | PR Log

    Recent research reporting on improvement in an 18 year old young woman undergoing chiropractic care reveals that chiropractic may play an important role in managing people with visual loss. ATLANTA - Aug. 1, 2017 - PRLog -- The research, reported in the Journal of Upper Cervical Chiropractic Research, includes a review of the literature demonstrating numerous effects on the eyes following chiropractic care including improvement in vision, visual acuity, oculomotor function, intraocular pressure, and pupillary size.

    Comment?

  17. Buxton activated; Gee recalled by TwinsRead the original story

    Tuesday Aug 1 | Minnesota Twins

    After trading closer Brandon Kintzler and lefty Jaime Garcia before Monday's non-waiver Trade Deadline, the Twins activated center fielder Byron Buxton from the 10-day disabled list and recalled right-hander Dillon Gee from Triple-A Rochester on Tuesday to take the vacated roster spots. Buxton had been out since July 14 with a strained groin and was expected to return on July 25. But he suffered migraine headaches last week, and he was sent out on a rehab assignment with Triple-A Rochester over the weekend.

    Comment?

  18. Tumor caused rare disorder for Oregon teacherRead the original story w/Photo

    Monday Jul 31 | The Columbian

    Medford resident Betsy Whispell was on her annual wind-surfing vacation on the Oregon Coast last year when a friend she hadn't seen in a year noticed that her face, hands and feet had grown abnormally large. "I was wearing a wetsuit on the deck.

    Comment?

  19. Biohaven Initiates Second Pivotal Phase III Clinical Trial Of Oral...Read the original story w/Photo

    Sunday Jul 30 | BioSpace

    "The launch of our second Phase 3 trial of rimegepant brings us one step closer to our goal of bringing an oral CGRP antagonist to market for patients suffering from migraine headaches," said , M.D., Chief Executive Officer at Biohaven. "We believe our Phase 2b data with rimegepant shows that this investigational agent has the potential to be a best-in-class migraine treatment option, and its oral route of administration will spare patients the need for intravenous or subcutaneous administration associated with other CGRP antagonists in development."

    Comment?

  20. Biohaven Pharmaceuticals LogoRead the original story w/Photo

    Jun 16, 2017 | PR Newswire

    "The launch of our second Phase 3 trial of rimegepant brings us one step closer to our goal of bringing an oral CGRP antagonist to market for patients suffering from migraine headaches," said , M.D., Chief Executive Officer at Biohaven. "We believe our Phase 2b data with rimegepant shows that this investigational agent has the potential to be a best-in-class migraine treatment option, and its oral route of administration will spare patients the need for intravenous or subcutaneous administration associated with other CGRP antagonists in development."

    Comment?